PhD neuroscientist with years of experience in preclinical models, in vivo pharmacology, early clinical development and project management. Track record of innovations in genetic medicine (RNA and Gene Therapy) for neurological and immunological diseases. Supervisory experience of PhD level and BS/MS level scientists.

Championed multiple discovery programs in neuro-immune interactions, autonomic hyperreflexia, and immuno-oncology. Managed a pipeline project in postsurgical pain management toward IND application and successful clinical development. Led several academic projects in sensory disorders using genetic and viral tools to publications in high-profile journals (Nature Medicine, Neuron, Journal of Allergy and Clinical Immunology, eLIFE).

Manager of cross-functional teams, with external partners and CROs on harnessing novel therapeutic modalities to tackle chronic pain and neurodegenerative diseases, and on building IP moat around the assets. Senior scientific prospector of more than 30 due diligence activities in scouting assets and M&A targets ranging from pre-clinical to human phase 2 stages.